Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis

Final draft guidance

Final draft guidance (PDF 314 KB)

Committee papers (PDF 1.04 MB)

Public committee slides (PDF 349 KB)

Appeal

Janssen : Appeal letter (MSWord 99 KB)

Myeloma UK : Appeal letter (MSWord 66 KB)

Janssen : Scrutiny letter (MSWord 88 KB)

Myeloma UK : Scrutiny letter (MSWord 90 KB)

Janssen : Response to scrutiny letter (MSWord 98 KB)

Myeloma UK : Response to scrutiny letter (MSWord 62 KB)

Janssen : Final scrutiny letter (MSWord 74 KB)

Myeloma UK : Final scrutiny letter (MSWord 71 KB)

Final draft guidance

Final appraisal document (PDF 303 KB)

Committee papers (PDF 831 KB)

Draft guidance: 1

Public committee slides (PDF 1.14 MB)

Committee papers (PDF 4.28 MB)

Appraisal consultation document (online commenting)

Appraisal consultation document (PDF version) (PDF 333 KB)

Committee meeting: 3

Equality impact assessment (Scoping) (PDF 131 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 281 KB)

Final scope (PDF 179 KB)

Draft scope post referral (PDF 183 KB)